US Stock MarketDetailed Quotes

CNBX Pharmaceuticals (CNBX)

Watchlist
  • 0.0002
  • -0.0001-20.00%
15min DelayClose Jan 22 15:42 ET
174.15KMarket Cap0.20P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

CNBX Pharmaceuticals (CNBX) Balance Sheet

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Nov 30, 2025
(FY)Aug 31, 2025
(Q4)Aug 31, 2025
(Q3)May 31, 2025
(Q2)Feb 28, 2025
(Q1)Nov 30, 2024
(FY)Aug 31, 2024
(Q4)Aug 31, 2024
(Q3)May 31, 2024
(Q2)Feb 29, 2024
Assets
Current assets
Cash, cash equivalents and short term investments
-55.57%7.7K
-42.80%15.11K
-42.80%15.11K
-81.41%13.65K
22.97%45.68K
-78.76%17.34K
-79.63%26.42K
-79.63%26.42K
66.26%73.41K
-22.21%37.14K
-Cash and cash equivalents
-55.57%7.7K
-42.80%15.11K
-42.80%15.11K
-81.41%13.65K
22.97%45.68K
-78.76%17.34K
-79.63%26.42K
-79.63%26.42K
66.26%73.41K
-22.21%37.14K
Receivables
-30.39%3.46K
-33.04%3.33K
-33.04%3.33K
-24.98%4.97K
-96.07%4.99K
-92.83%4.97K
-94.75%4.97K
-94.75%4.97K
-97.83%6.62K
107.53%126.78K
-Other receivables
-30.39%3.46K
-33.04%3.33K
-33.04%3.33K
-24.98%4.97K
-96.07%4.99K
-92.83%4.97K
-94.75%4.97K
-94.75%4.97K
-97.83%6.62K
107.53%126.78K
Total current assets
-49.96%11.16K
-41.25%18.44K
-41.25%18.44K
-76.74%18.62K
-69.09%50.66K
-85.22%22.31K
-86.01%31.38K
-86.01%31.38K
-77.06%80.03K
50.61%163.92K
Non current assets
Net PPE
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Investments and advances
----
----
----
----
----
----
--0
--0
----
----
Total non current assets
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Total assets
-49.96%11.16K
-41.25%18.44K
-41.25%18.44K
-76.74%18.62K
-69.09%50.66K
-94.24%22.31K
-93.71%31.38K
-93.71%31.38K
-87.91%80.03K
-64.52%163.92K
Liabilities
Current liabilities
Payables
10.69%1.34M
8.32%1.32M
8.32%1.32M
-1.99%1.22M
-0.61%1.22M
3.44%1.21M
3.71%1.22M
3.71%1.22M
0.13%1.24M
31.65%1.23M
-accounts payable
-12.23%45.63K
20.59%49.25K
20.59%49.25K
-78.27%41.24K
-72.80%62.94K
-78.84%51.99K
-87.84%40.84K
-87.84%40.84K
-81.30%189.82K
-67.44%231.38K
-Due to related parties current
11.72%1.29M
7.90%1.27M
7.90%1.27M
11.79%1.17M
16.12%1.16M
25.36%1.16M
40.46%1.18M
40.46%1.18M
369.82%1.05M
346.46%998.48K
Current debt and capital lease obligation
-6.15%1.25M
-7.56%1.2M
-7.56%1.2M
3.58%1.34M
8.22%1.4M
1.07%1.33M
-3.61%1.3M
-3.61%1.3M
-2.91%1.29M
-16.03%1.29M
-Current debt
-6.15%1.25M
-7.56%1.2M
-7.56%1.2M
3.58%1.34M
8.22%1.4M
1.07%1.33M
-3.61%1.3M
-3.61%1.3M
-2.91%1.29M
-16.03%1.29M
Current liabilities
1.87%2.58M
0.13%2.51M
0.13%2.51M
0.85%2.56M
3.91%2.62M
2.19%2.54M
-0.20%2.51M
-0.20%2.51M
-1.44%2.53M
1.98%2.52M
Non current liabilities
Total non current liabilities
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Total liabilities
1.87%2.58M
0.13%2.51M
0.13%2.51M
0.85%2.56M
3.91%2.62M
2.19%2.54M
-0.20%2.51M
-0.20%2.51M
-1.44%2.53M
1.98%2.52M
Shareholders'equity
Share capital
2,321.05%75.32K
1,680.65%55.4K
1,680.65%55.4K
197.36%9.25K
8.84%3.39K
9.89%3.11K
37.59%3.11K
37.59%3.11K
94.07%3.11K
1,301.35%3.11K
-common stock
2,321.05%75.32K
1,680.65%55.4K
1,680.65%55.4K
197.36%9.25K
8.84%3.39K
9.89%3.11K
37.59%3.11K
37.59%3.11K
94.07%3.11K
1,301.35%3.11K
-Preferred stock
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Retained earnings
-1.57%-25.38M
-1.26%-25.27M
-1.26%-25.27M
-0.90%-25.12M
-1.19%-25.06M
-2.25%-24.99M
-2.87%-24.95M
-2.87%-24.95M
-5.10%-24.89M
-5.24%-24.76M
Paid-in capital
1.17%22.73M
1.09%22.72M
1.09%22.72M
0.60%22.57M
0.37%22.48M
0.59%22.47M
1.04%22.47M
1.04%22.47M
20.33%22.44M
21.81%22.4M
Gains losses not affecting retained earnings
----
----
----
--0
--0
--0
--0
--0
----
----
Total stockholders'equity
-2.33%-2.57M
-0.66%-2.5M
-0.66%-2.5M
-3.38%-2.54M
-8.99%-2.57M
-20.02%-2.51M
-22.94%-2.48M
-22.94%-2.48M
-28.54%-2.45M
-17.25%-2.36M
Total equity
-2.33%-2.57M
-0.66%-2.5M
-0.66%-2.5M
-3.38%-2.54M
-8.99%-2.57M
-20.02%-2.51M
-22.94%-2.48M
-22.94%-2.48M
-28.54%-2.45M
-17.25%-2.36M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
(Q1)Nov 30, 2025(FY)Aug 31, 2025(Q4)Aug 31, 2025(Q3)May 31, 2025(Q2)Feb 28, 2025(Q1)Nov 30, 2024(FY)Aug 31, 2024(Q4)Aug 31, 2024(Q3)May 31, 2024(Q2)Feb 29, 2024
Assets
Current assets
Cash, cash equivalents and short term investments -55.57%7.7K-42.80%15.11K-42.80%15.11K-81.41%13.65K22.97%45.68K-78.76%17.34K-79.63%26.42K-79.63%26.42K66.26%73.41K-22.21%37.14K
-Cash and cash equivalents -55.57%7.7K-42.80%15.11K-42.80%15.11K-81.41%13.65K22.97%45.68K-78.76%17.34K-79.63%26.42K-79.63%26.42K66.26%73.41K-22.21%37.14K
Receivables -30.39%3.46K-33.04%3.33K-33.04%3.33K-24.98%4.97K-96.07%4.99K-92.83%4.97K-94.75%4.97K-94.75%4.97K-97.83%6.62K107.53%126.78K
-Other receivables -30.39%3.46K-33.04%3.33K-33.04%3.33K-24.98%4.97K-96.07%4.99K-92.83%4.97K-94.75%4.97K-94.75%4.97K-97.83%6.62K107.53%126.78K
Total current assets -49.96%11.16K-41.25%18.44K-41.25%18.44K-76.74%18.62K-69.09%50.66K-85.22%22.31K-86.01%31.38K-86.01%31.38K-77.06%80.03K50.61%163.92K
Non current assets
Net PPE --0--0--0--0--0--0--0--0--0--0
Investments and advances --------------------------0--0--------
Total non current assets --0--0--0--0--0--0--0--0--0--0
Total assets -49.96%11.16K-41.25%18.44K-41.25%18.44K-76.74%18.62K-69.09%50.66K-94.24%22.31K-93.71%31.38K-93.71%31.38K-87.91%80.03K-64.52%163.92K
Liabilities
Current liabilities
Payables 10.69%1.34M8.32%1.32M8.32%1.32M-1.99%1.22M-0.61%1.22M3.44%1.21M3.71%1.22M3.71%1.22M0.13%1.24M31.65%1.23M
-accounts payable -12.23%45.63K20.59%49.25K20.59%49.25K-78.27%41.24K-72.80%62.94K-78.84%51.99K-87.84%40.84K-87.84%40.84K-81.30%189.82K-67.44%231.38K
-Due to related parties current 11.72%1.29M7.90%1.27M7.90%1.27M11.79%1.17M16.12%1.16M25.36%1.16M40.46%1.18M40.46%1.18M369.82%1.05M346.46%998.48K
Current debt and capital lease obligation -6.15%1.25M-7.56%1.2M-7.56%1.2M3.58%1.34M8.22%1.4M1.07%1.33M-3.61%1.3M-3.61%1.3M-2.91%1.29M-16.03%1.29M
-Current debt -6.15%1.25M-7.56%1.2M-7.56%1.2M3.58%1.34M8.22%1.4M1.07%1.33M-3.61%1.3M-3.61%1.3M-2.91%1.29M-16.03%1.29M
Current liabilities 1.87%2.58M0.13%2.51M0.13%2.51M0.85%2.56M3.91%2.62M2.19%2.54M-0.20%2.51M-0.20%2.51M-1.44%2.53M1.98%2.52M
Non current liabilities
Total non current liabilities --0--0--0--0--0--0--0--0--0--0
Total liabilities 1.87%2.58M0.13%2.51M0.13%2.51M0.85%2.56M3.91%2.62M2.19%2.54M-0.20%2.51M-0.20%2.51M-1.44%2.53M1.98%2.52M
Shareholders'equity
Share capital 2,321.05%75.32K1,680.65%55.4K1,680.65%55.4K197.36%9.25K8.84%3.39K9.89%3.11K37.59%3.11K37.59%3.11K94.07%3.11K1,301.35%3.11K
-common stock 2,321.05%75.32K1,680.65%55.4K1,680.65%55.4K197.36%9.25K8.84%3.39K9.89%3.11K37.59%3.11K37.59%3.11K94.07%3.11K1,301.35%3.11K
-Preferred stock --0--0--0--0--0--0--0--0--0--0
Retained earnings -1.57%-25.38M-1.26%-25.27M-1.26%-25.27M-0.90%-25.12M-1.19%-25.06M-2.25%-24.99M-2.87%-24.95M-2.87%-24.95M-5.10%-24.89M-5.24%-24.76M
Paid-in capital 1.17%22.73M1.09%22.72M1.09%22.72M0.60%22.57M0.37%22.48M0.59%22.47M1.04%22.47M1.04%22.47M20.33%22.44M21.81%22.4M
Gains losses not affecting retained earnings --------------0--0--0--0--0--------
Total stockholders'equity -2.33%-2.57M-0.66%-2.5M-0.66%-2.5M-3.38%-2.54M-8.99%-2.57M-20.02%-2.51M-22.94%-2.48M-22.94%-2.48M-28.54%-2.45M-17.25%-2.36M
Total equity -2.33%-2.57M-0.66%-2.5M-0.66%-2.5M-3.38%-2.54M-8.99%-2.57M-20.02%-2.51M-22.94%-2.48M-22.94%-2.48M-28.54%-2.45M-17.25%-2.36M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions --Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes------
Market Insights
Nancy Pelosi Portfolio
No. Symbol % Chg
Sample Name
Sample Code
 +4.65%
Sample Name
Sample Code
 +4.15%
Sample Name
Sample Code
 +2.94%
4
Clean Energy Fuels
CLNE
+2.70%
5
American Express
AXP
+2.34%
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +24.00%
Sample Name
Sample Code
 +7.99%
Sample Name
Sample Code
 +7.44%
4
KE Holdings
BEKE
+5.08%
5
NIO Inc
NIO
+4.61%
View More
The Fed Delivers Third Consecutive Rate Cut as Expected! How to Position for Year-End U.S. Equity Ma
On December 19, the Bank of Japan raised interest rates by 25 basis points as expected, in line with market forecasts. On the evening of Dec Show More
December FOMC Interest Rate Meeting
[Opportunity Express] MRVL Continues to Bet on Optical Interconnects: Is Now a Good Time to Enter the Market?

- No more -